The American College of Cardiology (ACC) Annual Scientific Session is the kind of meeting where late-breaking trial results generate national headlines. But it's one of a number of meetings drawing attention in the CME community for compliance reasons.
Bowing to outraged patient advocates, NYU Child Study Center said it will halt its controversial print and outdoor ad campaign aimed at raising awareness of mental health problems in children.
Indevus Pharmaceuticals has received a non-approvable letter from FDA for Valstar related to its chemistry, manufacturing and controls NDA supplement submitted to the FDA in May 2007.
Valeant Pharmaceuticals International and Three Rivers Pharmaceuticals jointly announced that they have signed a definitive agreement for Valeant to divest the US and Canadian rights to hepatitis C drug Infergen (interferon alfacon-1) to Three Rivers.
Webcast
5 BIG REASONS for taking pharmaceutical marketing online
Available on demand Many pharmaceutical marketers are still unsure about entering the digital landscape and even less certain of what to do when they get there. Interactive marketing experts from Google and pharmaceutical companies discuss why marketers should take the plunge and how it could positively impact their businesses. Click here for more information and to register for this webcast.
To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.
All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam filter rules, please
use this domain name.
Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York
N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150 http://www.mmm-online.com/
_8171_8173.jpg)
You are subscribed as: %%EMAIL%%